Clinical efficacy and safety of hypernormal shortened door to needle time (DNT) plus individualized low-dose alteplase therapy in treating acute ischemic stroke

OBJECTIVE: This study aims to observe the clinical efficacies of hyper-early low-dose alteplase thrombolysis in treating acute ischemic stroke (AIS). METHODS: Two hundred twenty AIS patients were randomly divided into group A (90 cases), group B (90 cases), and group C (40 cases). The National Insti...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Mei, Lei, Hongyan, Cui, Yansen, Yang, Daiqun, Wang, Liquang, Wang, Ziran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017082/
https://www.ncbi.nlm.nih.gov/pubmed/27648019
http://dx.doi.org/10.12669/pjms.324.9518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017082/
https://www.ncbi.nlm.nih.gov/pubmed/27648019
http://dx.doi.org/10.12669/pjms.324.9518

Ejemplares similares